Zheng Quan Zhi Xing·2025-08-21 16:28Core Viewpoint - The remuneration committee of the board of directors of Nuo Cheng Jian Hua Pharmaceutical Co., Ltd. has reviewed and approved the list of reserved grant incentive objects for the 2024 Science and Technology Innovation Board restricted stock incentive plan, confirming that all selected individuals meet the necessary legal and regulatory conditions [1][2]. Group 1: Incentive Plan Overview - The incentive plan is based on various legal frameworks, including the Company Law and the Securities Law of the People's Republic of China, as well as specific regulations governing stock incentives on the Science and Technology Innovation Board [1]. - The plan includes a reserved grant date set for August 20, 2025, with a grant price of 6.65 yuan per share for 246,755 shares of restricted stock to 91 eligible incentive objects [2]. Group 2: Eligibility Criteria - Individuals who have been deemed inappropriate candidates by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months are excluded from being incentive objects [1]. - Those who have faced administrative penalties or market entry bans due to significant violations of laws and regulations in the past year are also ineligible [1]. - The eligibility criteria further include compliance with the stipulations of the Company Law and other relevant laws that prohibit certain individuals from participating in stock incentive plans [1].